Veterinary Anti-infectives Market
Report ID: SQMIG35I2737
Report ID: SQMIG35I2737
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35I2737 |
Region:
Global |
Published Date: May, 2026
Pages:
157
|Tables:
148
|Figures:
78
Global Veterinary Anti-Infectives Market size was valued at USD 8.6 Billion in 2024 and is poised to grow from USD 9.22 Billion in 2025 to USD 16.08 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).
The main factor driving the veterinary anti-infectives market is the increasing need for better infection control in both livestock and pets. This includes antibiotics, antivirals, antifungals, and diagnostic tools, which play a crucial role in maintaining animal health. Healthy animals ensure food security and public safety, as well as provide economic stability. Historically, the market expanded due to intensified farming and more households having pets. As Asian countries increased intensive poultry and pork farming, there was more routine use of antibiotics. Meanwhile, an uptick in veterinary care in North America and Europe pushed spending towards advanced treatments. Consequently, this led to global pharmaceutical advancements and stricter regulations.
Antimicrobial resistance is a major force influencing growth in this field. It reduces broad-spectrum drugs' effectiveness, making vets and producers switch methods. With more resistance, regulators curb preventive antibiotic usage, boosting demands for quick diagnostics, narrower spectrum treatments, and other options like bacteriophages and immunotherapies. For example, on-farm PCR tests for mastitis aid in precise treatment and cut down on drug use. Phage tests in poultry tamp down Salmonella without standard antibiotics, opening up business chances for diagnostic firms, small biologics creators, and those offering stewardship programs.
How is AI Improving Antimicrobial Stewardship in the Veterinary Anti-infectives Market?
AI is boosting antimicrobial stewardship in the veterinary anti-infectives market by improving diagnostics, guiding prescriptions, and helping keep track of resistance. It does this through faster pathogen ID, predictions on resistance, and tools for better clinical decisions that cut the need for broad-spectrum therapies. The market's setup pushes for diagnostic-led care because vets and producers want tools to stop misuse and back up the One Health goals. Some real-world examples: AI analyzing cytology results, machine learning from genomic resistance data, and clinic-level support systems that make prescribing both more consistent and more targeted. Zomedica showed this in January 2026 when they added AI to their TRUVIEW microscopy. This sped up cytology review, pointed out likely pathogens, let clinicians pick narrower spectrum drugs sooner, and made the clinic run smoother while pushing for diagnostics and software-driven anti-infective tactics.
Market snapshot - (2026-2033)
Global Market Size
USD 8.6 Billion
Largest Segment
Antibiotics
Fastest Growth
Antiparasitic Anti-infectives
Growth Rate
7.2% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global veterinary anti-infectives market is segmented by product type, animal type, route of administration, distribution channel, end user and region. Based on product type, the market is segmented into Antibiotics, Antivirals, Antifungals and Antiparasitic Anti-infectives. Based on animal type, the market is segmented into Companion Animals and Livestock Animals. Based on route of administration, the market is segmented into Oral, Injectable, Topical, Intramammary and Others. Based on distribution channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Veterinary Pharmacies, E-commerce and Feed Mills & Agricultural Supply Stores. Based on end user, the market is segmented into Veterinary Hospitals & Clinics, Animal Farms, Pet Owners and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Antibiotics dominate because their wide use and proven effectiveness make them key for treating bacterial diseases in pets and livestock. Since they work and fit well with existing health systems, vets and owners prefer them. This practical side impacts how suppliers decide to invest and manage resources in the market.
However, the anti-parasitic treatments are growing at the fastest rate. With more focus on stopping parasites and new forms that are easier to use, these treatments are becoming bigger. They're now used more for prevention in both pets and farm animals. New innovations in long-lasting and easy-to-apply methods are pushing the growth of this sector, opening up more business chances and expanding the market.
Injectable segment leads because injectables give rapid onset, predictability in how the drug moves in the body, and reliable delivery – all key to severe infections and large-scale treatments. Veterinarians really like using injectables for controlled dosing and handling urgent cases. Plus, these shots work great when owners can't administer meds themselves. With advances in long-lasting injectables, we're seeing even more benefits that make treatment easier.
On the other hand, oral medications are seeing the fastest growth. People want easier-to-give-at-home options, and there's a rise in tasty, long-acting pills and capsules that boost patient compliance. Drugs are now more available at retail stores and online too. This convenience is cutting down on vet visits and opening more outpatient opportunities. All this is fueling even more product development and commercial growth in this sector.
To get detailed segments analysis, Request a Free Sample Report
North America dominates the global vet anti-infectives market thanks to its solid combo of advanced infrastructure, top R&D skills, and slick commercial channels. Academic and industry teams work closely with regulators to speed up product creation and take-up. The region's animal health services are robust, and vet networks are extensive, which helps spread new products widely. They've got mature markets along with easy access to diagnostic tools and a sophisticated supply chain, allowing quick adoption of cutting-edge cures and stewardship schemes. Private and public money pours in for translation research, and smooth review processes fuel innovation. Surveillance systems keep everyone informed on usage and manage product lifecycles efficiently.
The Veterinary Anti-infectives Market in the US thrives because of strong clinical skills, solid industry ties, and great vet network connections. Private investors and research teamwork boost new drug creation and get them to market. Existing distribution routes and know-how in regulatory dealings speed up approvals and sales. With pet owners and producers caring a lot about animal health, there's high take-up of smart diagnostics and care programs. This keeps the anti-infectives field healthy and robust.
The Veterinary Anti-infectives Market in Canada is influenced by research networks, a focus on responsible use, and close work between industries and regulators. Plus, there's a big push on herd health programs and preventive services, which boosts demand for both livestock and pet treatments. The efficient spread of these products across different areas and how adaptable vet practices are also help new formulations get accepted. Add to that policies that promote conservation and money put into diagnostics, which makes the market resilient and innovative.
Expansion in Europe comes from regulatory harmony, good antimicrobial stewardship, and robust vet networks focusing on animal welfare and public health. Producers and pet owners are getting smarter too, leading them to seek out better-targeted treatments and diagnosis-linked prescriptions. Manufacturing companies, along with research institutes and regulators, work together across borders, speeding up how fast new ideas hit the field. More attention to green farming practices and preventive vet services means there's a push for fresh anti-infective methods. Markets are expanding, thanks to easier ways to get paid and local production boosts, making supplies steadier and creating competition. This speeds up growth in key areas. Quick diagnosis tech and precise dosing gadgets are becoming more common, boosting patient results while promoting wise drug prescribing. With public and private groups teaming up and setting solid care standards, businesses can scale their sales better and keep investors happy.
The Veterinary Anti-infectives Market in Germany is solid, thanks to a robust industrial base, top-notch research, and smooth supply chains. Quality focus and cooperation with regulators drive new product introductions. Both farm advisors and vets advocate smart medicine usage. Universities, manufacturers, and diagnostic companies work together to innovate, keeping Germany at the front of Europe in this field.
The Veterinary Anti-infectives Market in the United Kingdom is pretty lively. It's driven by growing research clusters, active clinical networks, and a good amount of collaboration between the industry and academics. Plus, there's a responsive regulatory environment that backs prudent prescribing and promotes new treatments. Startup activities draw investment toward customized products and diagnostic tools. Efforts to strengthen distribution and boost education help spread innovations and expand market access for both companion and production animals.
The Veterinary Anti-infectives Market in France is doing really well, backed by biotech ecosystems, supportive policies, and investments in animal health. Research institutes work closely with commercial devs to speed up new therapy and delivery system creation. Plus, a focus on preventive vet services and overall herd health boosts need for specialty products. Local factories and collaboration projects help new entrants get their footing nationally, making products accessible to farmers and pet doctors alike.
Asia Pacific is becoming more influential because of strategic investments in research, improved manufacturing, and better vet services. This supports wider access to anti-infective drugs. Plus, there's more emphasis on diagnostics and specific treatment plans, which makes therapies work better and encourages responsible usage. Collaboration on aligning regulations and higher adoption by livestock and pet owners boosts the need for various drug forms. Local innovation, an increase in contract manufacturing, and joint public-private efforts to step up monitoring and care management boost the region's market appeal. More educational opportunities for vets enhance the number of clinicians promoting smart drug use. Additionally, digital tools and telemedicine now extend diagnoses to remote farms. Enhanced cold-chain systems also help with the distribution of temperature-sensitive products. Finally, ties with major international companies connect local manufacturing to the world market and draw in extra funding for anti-infective developments.
The Veterinary Anti-infectives Market in Japan stands out due to its top-tier pharmaceutical know-how and strict quality controls. They put a lot of effort into high-end pet care and precise treatments, driving demand for new products and tests. Academic teams work closely with companies to develop stuff, and solid manufacturing processes ensure consistency. On top of that, focused stewardship and educational programs promote proper usage, making the market even more sophisticated.
The Veterinary Anti-infectives Market in South Korea is thriving due to a booming pharmaceutical industry, a push toward biotechnology, and backing from the government. It’s also benefiting from solid contract manufacturing, along with rising domestic demand. Plus, digital diagnostics and precision medicine are making treatments more effective. Collaboration in research and efforts to train the workforce are boosting clinical skills and setting the stage for further progress and global cooperation.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Companion Animal Ownership
More companion animals mean more vet visits and an increased need for anti-infective products. People want their pets to be healthy and are OK with spending more on prevention and treatment, so they go along with prescriptions for antibiotics and antifungals. Due to the increase in medications, drug makers are driven to create, distribute, and instruct on new stuff. This growing market gets a boost from more vet visits, heightened worries about zoonotic diseases, and a stronger wish to keep pets healthy. All these factors contribute to the rise in anti-infective product development.
Expansion of Livestock Production
Commercial livestock growth boosts the need for managing diseases, increasing dependence on vet anti-infectives to keep herds healthy and productive. With intensive farming comes higher infection risks, so producers and vets look for good antimicrobial treatments to stop outbreaks and cut animal deaths. The desire for dependable cures pushes manufacturers to broaden their range of drug formulas, spread distribution, and ramp up farm-focused support services. As producers' needs match what's available on the market, there's more buying, regular use of therapies, and investment in large-animal solutions, driving the industry forward.
Antimicrobial Resistance Concerns
Antimicrobial resistance is worrying more people, so now there are stricter rules and vets are being more careful with antibiotics. They're under pressure to avoid using these drugs just preventively or for boosting growth. Instead, they go for targeted treatments and other options. The regulators and the industry itself say antimicrobials shouldn't be used all the time, which means fewer sales based on quantity. Because of this, what's growing is a need for specialized products and diagnostics. These changes slow down the growth of regular anti-infectives since they create roadblocks and force companies to change their product lines and how they promote them.
Stringent Regulatory Approval Processes
The complex and time-consuming regulatory processes for veterinary drugs slow down how fast new anti-infectives hit the market. Companies have to deal with different national rules, heavy safety tests, and ongoing checks after approval. This makes development take longer, be more expensive, and risky. The challenges block small companies from joining and keep investments in new products low. Because of this, only well-established firms put stuff out, leaving fewer options and stopping quick updates to existing therapies. Overall market growth slows, even when there's still lots of demand.
Request Free Customization of this report to help us to meet your business objectives.
The global veterinary anti-infectives market is competitive because of company mergers, tech advancements, and innovation. Major deals like Elanco acquiring Bayer Animal Health in 2020 and Ceva buying Scout Bio in 2024 have reshaped the industry. At the same time, firms create new products and diagnostic tools; for instance, Merck Animal Health launched AROVYN in 2022. They also team up with startups to develop antibiotic alternatives, like their work with BioAZ.
Companion Animal Demand: Competitors are now focusing on preventive care and treatments for their pets, boosting the use of veterinary anti-infectives. As people buy better quality products and interact more with vets, companies are pushed to create specialized medications and easier ways to dose them. To keep up, businesses are developing new drug delivery methods, forming service partnerships, and offering educational programs for both vets and owners. All this highlights how important branded pet medicines and long-term care have become in vet pharma.
Point of Care Diagnostics: Rapid diagnostics and digital tools are changing how prescribing works in vet meds, allowing for quicker and more confident decisions. Point-of-care tests, cloud-connected lab platforms, and decision-support systems help choose targeted treatments and improve monitoring. Plus, manufacturers and service providers are partnering up, offering clinician training and building data platforms that play nicely together. These efforts streamline workflows, boost efficient product use, strengthen the case for new therapies, and create chances for service-led offers in both companion and production of animal care.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means ofPrimary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global veterinary anti-infectives market is growing thanks to more people owning pet animals, which drives up demand for health products. Another factor is the growth of farm animal businesses, creating a need for bigger disease control measures. However, worries about drug resistance are pushing for better management practices and shifting interest towards diagnostic tools and other solutions. North America leads this market because of its advanced pet care setup and effective processes for research, development, and selling such products. Antibiotics are still the biggest product type in this market, used widely in both pets and livestock because they work well and are commonly accepted. Plus, there's a rising focus on diagnostics and new innovations in the field.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 8.6 Billion |
| Market size value in 2033 | USD 16.08 Billion |
| Growth Rate | 7.2% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Veterinary Anti-infectives Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Veterinary Anti-infectives Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Veterinary Anti-infectives Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Veterinary Anti-infectives Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Veterinary Anti-Infectives Market size was valued at USD 8.6 Billion in 2024 and is poised to grow from USD 9.22 Billion in 2025 to USD 16.08 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).
Competition in the global veterinary anti-infectives market is driven by consolidation and tech differentiation, with landmark M&A such as Elanco’s 2020 acquisition of Bayer Animal Health and Ceva’s 2024 purchase of Scout Bio. Simultaneously firms pursue product and diagnostic innovation, exemplified by Merck Animal Health’s 2022 launch of AROVYN and collaborations with startups developing antibiotic alternatives such as BioAZ. 'Zoetis', 'Elanco Animal Health', 'Merck Animal Health', 'Boehringer Ingelheim Animal Health', 'Ceva Santé Animale', 'Virbac', 'Vetoquinol', 'Dechra Pharmaceuticals', 'Phibro Animal Health', 'Huvepharma', 'Norbrook Laboratories', 'HIPRA', 'Bimeda', 'Indian Immunologicals Limited', 'Neogen Corporation', 'Kyoritsu Seiyaku Corporation', 'Endovac Animal Health', 'Chanelle Pharma', 'Ashish Life Science', 'Zydus Animal Health'
Increasing numbers of companion animals have led to greater demand for veterinary care, which expands the need for anti-infective products. Pet owners prioritize health and seek preventive and therapeutic treatments, prompting veterinarians to prescribe antibiotics and antifungals more frequently. This sustained demand encourages manufacturers to invest in product development, distribution, and educational outreach for appropriate usage. The resulting market expansion is supported by growing clinic visits, enhanced awareness of zoonotic risks, and willingness to spend on pet health, collectively driving procurement and innovation in anti-infectives.
Companion Animal Demand: Growing demand for companion animal healthcare is driving expanded adoption of veterinary anti-infectives as owners prioritize preventive and treatment options. Premiumization of pet products, increased veterinary engagement, and higher expectations for treatment outcomes encourage manufacturers to develop targeted formulations and convenient dosing. Market participants are responding with enhanced drug delivery formats, partnerships across clinical services, and tailored education for practitioners and owners. This trend elevates the strategic importance of branded therapeutics and chronic care pathways within the veterinary pharmaceutical landscape.
Why does North America Dominate the Global Veterinary Anti-infectives Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
